ES2066605T3 - Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica. - Google Patents

Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.

Info

Publication number
ES2066605T3
ES2066605T3 ES92906408T ES92906408T ES2066605T3 ES 2066605 T3 ES2066605 T3 ES 2066605T3 ES 92906408 T ES92906408 T ES 92906408T ES 92906408 T ES92906408 T ES 92906408T ES 2066605 T3 ES2066605 T3 ES 2066605T3
Authority
ES
Spain
Prior art keywords
preparation
application
thioureas
therapeutics
ureas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92906408T
Other languages
English (en)
Inventor
Jean-Louis Vidaluc
Denis Bigg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of ES2066605T3 publication Critical patent/ES2066605T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVAS UREAS Y TIOUREAS QUE RESPONDEN A LA FORMULA GENERAL (I), ASI COMO LAS SALES TERAPEUTICAMENTE ACEPTABLES DE ESTAS MOLECULAS. LA INVENCION CONCIERNE IGUALMENTE A LA APLICACION DE LOS COMPUESTOS DE FORMULA (I) EN TERAPEUTICA Y PROCESOS DE PREPARACION.
ES92906408T 1991-02-14 1992-02-12 Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica. Expired - Lifetime ES2066605T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9101740A FR2672888B1 (fr) 1991-02-14 1991-02-14 Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
ES2066605T3 true ES2066605T3 (es) 1995-03-01

Family

ID=9409713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92906408T Expired - Lifetime ES2066605T3 (es) 1991-02-14 1992-02-12 Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.

Country Status (9)

Country Link
EP (1) EP0571511B1 (es)
JP (1) JPH06507387A (es)
AT (1) ATE115131T1 (es)
DE (1) DE69200840T2 (es)
DK (1) DK0571511T3 (es)
ES (1) ES2066605T3 (es)
FR (1) FR2672888B1 (es)
GR (1) GR3015132T3 (es)
WO (1) WO1992014710A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1535682A (zh) 1998-09-30 2004-10-13 ����ҩƷ��ҵ��ʽ���� 改善膀胱排泄能力的药物
US6962926B2 (en) 2001-01-31 2005-11-08 Telik, Inc. Antagonist of MCP-1 function, and compositions and methods of use thereof
US6670364B2 (en) 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
TWI245761B (en) 2001-03-01 2005-12-21 Telik Inc Antagonists of MCP-1 function and methods of use thereof
TWI236474B (en) * 2001-04-03 2005-07-21 Telik Inc Antagonists of MCP-1 function and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071524A (en) * 1976-11-08 1978-01-31 Riker Laboratories, Inc. Derivatives of urea
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
FR2672888A1 (fr) 1992-08-21
JPH06507387A (ja) 1994-08-25
DE69200840D1 (de) 1995-01-19
EP0571511A1 (fr) 1993-12-01
FR2672888B1 (fr) 1994-02-04
WO1992014710A1 (fr) 1992-09-03
DK0571511T3 (da) 1995-05-08
GR3015132T3 (en) 1995-05-31
EP0571511B1 (fr) 1994-12-07
ATE115131T1 (de) 1994-12-15
DE69200840T2 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
HU9303458D0 (en) Process for producing sulfonamides and pharmaceutical preparations containing them
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
DK0850215T3 (da) N-(aroyl)glycinhydroxamsyrederivater og beslægtede forbindelser
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
MY131458A (en) Pyrolopyrimidine compounds
DE3480474D1 (de) 2-amino-5-hydroxy-4-methylpyrimidine derivatives
FR2677019B1 (fr) Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
AP9701041A0 (en) Pyridylpyrrole compounds.
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
TR199801840A2 (xx) Yeni imidazolidin t�revleri ve bunlar� i�eren farmakolojik preparatlar.
ES2007177A6 (es) Procedimiento para preparar amidas y tioamidas del acido 1'-desoxi-1'-(6-amino-9-purinil)-b-d-ribofuranuronico sustituidas en la posicion 2.
NO180334C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive difluorstatonanaloger
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
DK102892A (da) Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter
ES2066605T3 (es) Nuevas ureas y tioureas, su preparacion y su aplicacion en terapeutica.
SE8405588D0 (sv) New compounds
DE69030665T2 (de) (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate
ES2128313T3 (es) Naftalimidas n-substituidas, su obtencion y empleo.
DK0720617T3 (da) Hidtil ukendte urethanholdige aminosteroidforbindelser
ES2052635T3 (es) Nuevas silil alquilen aminas sustituidas.
ES2073850T3 (es) Aductos con etanol de 3-hidroxicromanos sustituidos con sulfonilo en posicion 6 y su utilizacion como agentes para inhalacion en enfermedades.
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
DK0580624T3 (da) Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571511

Country of ref document: ES